CYCLODEXTRIN-BASED POLYANIONIC AND NON-IONIC DENDRIMERS
    81.
    发明公开
    CYCLODEXTRIN-BASED POLYANIONIC AND NON-IONIC DENDRIMERS 审中-公开
    CYCLODEXTRINBASIERTE POLANANISISCHE UND NICHTIONISCHE DENDRIMERE

    公开(公告)号:EP3149052A1

    公开(公告)日:2017-04-05

    申请号:EP15799950.9

    申请日:2015-03-31

    IPC分类号: C08B37/16 A61K47/40

    摘要: The present application provides polyanionic and non-ionic cyclodextrin-based compounds, and methods of manufacturing them. The compounds comprise a negatively-charged or neutral moiety (and, for polyanionic compounds, a suitable counter cation), one or more linkers, optionally one or more bridging groups, a cyclodextrin, and one or more substituents on the cyclodextrin. The compounds can be used in pharmaceutical compositions, and as excipients or carriers of guest molecules.

    摘要翻译: 本申请提供聚阴离子和非离子环糊精基化合物及其制备方法。 所述化合物包含负电荷或中性部分(对于聚阴离子化合物,合适的抗衡阳离子),一个或多个连接体,任选一个或多个桥连基团,环糊精和环糊精上的一个或多个取代基。 该化合物可用于药物组合物,以及作为客体分子的赋形剂或载体。

    LIPOSOMAL MUPIROCIN
    83.
    发明公开
    LIPOSOMAL MUPIROCIN 审中-公开
    利培酮MUPIROCIN

    公开(公告)号:EP3142642A1

    公开(公告)日:2017-03-22

    申请号:EP15722359.5

    申请日:2015-04-08

    摘要: Provided are liposomes encapsulating mupirocin, with particular benefit for systemic therapeutically effective delivery. Also provided herein are pharmaceutical compositions including the liposomes and methods of using them. The liposomes include a lipid membrane and an intraliposomal compartment, the intraliposomal compartment encapsulating mupirocin, at least one cyclodextrin compound and a pH dependent ionizable anion, e.g. acetate.

    摘要翻译: 提供包封莫匹罗星的脂质体,特别有益于全身治疗有效递送。 本文还提供包含脂质体的药物组合物及其使用方法。 脂质体包括脂质膜和脂质体内隔室,包封莫匹罗星的脂质体内区域,至少一种环糊精化合物和pH依赖性可电离阴离子,例如, 醋酸。

    LIQUID FORMULATION COMPRISING MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PREPARING SAME
    86.
    发明公开
    LIQUID FORMULATION COMPRISING MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PREPARING SAME 审中-公开
    其液体制剂孟鲁司特或药学上可接受的盐和过程及其制造

    公开(公告)号:EP3082766A1

    公开(公告)日:2016-10-26

    申请号:EP14871056.9

    申请日:2014-12-17

    摘要: The present invention relates to a liquid formulation comprising a solubilizer and montelukast or pharmaceutically acceptable salt thereof in a solution state as an active ingredient, and a method for preparing same. The liquid formulation of the present invention allows montelukast or pharmaceutically acceptable salt thereof to be substantially dissolved and present in a solution state, thereby preventing decrease of dissolution over time and increasing its bioavailability. In addition, because the liquid formulation of the present invention shows superior stability, taste and flavor, its medication compliance can be enhanced, and it can be effectively utilized for asthma and allergic rhinitis patients.

    摘要翻译: 本发明涉及一种液体制剂在溶液状态下其包含增溶剂和孟鲁司特或其药学上可接受的盐作为活性成分的,以及用于制备其的方法。 本发明的液体制剂允许在溶液状态或孟鲁司特或其可药用盐也可以基本上溶解和存在,从而防止溶解的随时间降低,并提高其生物利用度。 此外,因为本发明的液体制剂,显示出优异的稳定性,味道和香味,其服药依从性可以提高,并且可以有效地用于治疗哮喘和过敏性鼻炎的患者。

    METHOD OF PRODUCING PURIFIED STILBENE COMPOUNDS
    89.
    发明公开
    METHOD OF PRODUCING PURIFIED STILBENE COMPOUNDS 审中-公开
    VERFAHREN ZUR HERSTELLUNG GEREINIGTER STILBENVERBINDUNGEN

    公开(公告)号:EP3009132A1

    公开(公告)日:2016-04-20

    申请号:EP15190390.3

    申请日:2015-10-19

    IPC分类号: A61K31/05 A61K47/40

    摘要: The present invention is directed to provide a precipitate obtained by adding γ-cyclodextrin to a liquid containing a stilbene compound. The precipitate according to the present invention is used as the precipitate obtained by adding γ-cyclodextrin to the liquid containing a stilbene compound.

    摘要翻译: 本发明旨在提供通过将β-环糊精加入到含有二苯乙烯化合物的液体中获得的沉淀物。 将本发明的沉淀物用作通过将β-环糊精加入到含有二苯乙烯化合物的液体中获得的沉淀物。